Role of systemic chemotherapy in urothelial urinary bladder cancer
about
Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder CancerInhibiting cytoplasmic accumulation of HuR synergizes genotoxic agents in urothelial carcinoma of the bladder.The novel role of pyrvinium in cancer therapy.In vitro and in vivo targeting of bladder carcinoma with metformin in combination with cisplatin
P2860
Role of systemic chemotherapy in urothelial urinary bladder cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Role of systemic chemotherapy in urothelial urinary bladder cancer
@ast
Role of systemic chemotherapy in urothelial urinary bladder cancer
@en
Role of systemic chemotherapy in urothelial urinary bladder cancer
@nl
type
label
Role of systemic chemotherapy in urothelial urinary bladder cancer
@ast
Role of systemic chemotherapy in urothelial urinary bladder cancer
@en
Role of systemic chemotherapy in urothelial urinary bladder cancer
@nl
prefLabel
Role of systemic chemotherapy in urothelial urinary bladder cancer
@ast
Role of systemic chemotherapy in urothelial urinary bladder cancer
@en
Role of systemic chemotherapy in urothelial urinary bladder cancer
@nl
P2860
P3181
P1433
P1476
Role of systemic chemotherapy in urothelial urinary bladder cancer
@en
P2093
P2860
P304
P3181
P356
10.1177/107327481302000308
P407
P577
2013-07-01T00:00:00Z